scispace - formally typeset
M

Mark Blades

Researcher at Queen Mary University of London

Publications -  8
Citations -  978

Mark Blades is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Arthritis & Follicular dendritic cells. The author has an hindex of 6, co-authored 8 publications receiving 911 citations. Previous affiliations of Mark Blades include King's College London.

Papers
More filters
Journal ArticleDOI

Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium

TL;DR: It is demonstrated that FDC+ follicular units invariably express AID and are surrounded by ACPA-producing plasma cells, providing strong evidence that ectopic lymphoid structures in the RA synovium are functional and support autoantibody production.
Journal ArticleDOI

Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome

TL;DR: The acquisition of lymphoid features byinflammatory foci in SS is critically associated with the enlargement of the inflammatory foci and with the expression of CXCL13 and CCL21 within the infiltrate, but is not associated with their expression by epithelial cells.
Journal ArticleDOI

Acute Serum Amyloid A Induces Migration, Angiogenesis, and Inflammation in Synovial Cells In Vitro and in a Human Rheumatoid Arthritis/SCID Mouse Chimera Model

TL;DR: In the RA synovial/SCID mouse chimera model, it is demonstrated for the first time in vivo that A-SAA directly induces monocyte migration from the murine circulation into RAsynovial grafts, synovIAL cell proliferation, and angiogenesis critical to RA pathogenesis.
Journal ArticleDOI

The role of substance P in microvascular responses in murine joint inflammation

TL;DR: Novel techniques are used in WT and NK1 knockout mice to show that SP can modulate vascular tone and permeability in the inflamed joint via activation of the NK1 receptor and that SP‐induced responses are more pronounced where pre‐existing inflammation is present.